Is SCHD a Good ETF to Buy?
With around $65.7 billion in net assets, Schwab’s US Dividend…
Buy
98
CTOR Quote, Financials, Valuation and Earnings
Last price:
$1.36
Seasonality move
:
--
Day range:
$1.43 - $1.58
52-week range:
$0.85 - $4.42
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
516.6K
Avg. volume:
3.9M
1-year change:
--
Market cap:
$110.2M
Revenue:
--
EPS (TTM):
--
Earnings Data
Next earnings date for CTOR
May 20
2025
Most recent earnings per share
--
Missed by --
(Jan 8/2025)
Consensus Estimate
--
(Jan 8/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CTOR Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 05/20/2025 | Q1 | $5.7M | -- | -- | -- | -- |
| 02/28/2025 | Q4 | -- | -- | -- | -- | -- |
| 12/27/2024 | Q3 | -- | -- | -- | -- | -- |
Citius Oncology Earnings Questions
-
How Much did Citius Oncology Generate in Revenue Last Quarter?
Citius Oncology reported -- worth of top line sales in its most recent quarter.
-
Did Citius Oncology Beat Earnings Last Quarter?
Citius Oncology announced earnings per share of -- which represents a miss of analyst forecast a -- per share.
-
Is Citius Oncology Profitable?
Citius Oncology reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Citius Oncology EPS Next Year?
Citius Oncology's earnings are forecast to grow from -$0.31 per share to -- per share next year representing an increase of --.
-
When is Citius Oncology's Earnings Date?
Citius Oncology's next earnings date is May 20, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is NAIL a Good ETF to Buy?
If you’re thinking about buying the NAIL ETF, this article…
3 High Dividend Dow Jones Stocks
Thanks to surging stock prices over the past two years,…
Stock Ideas
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 125x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
NARI alert for Jan 7
Inari Medical [NARI] is up 22.25% over the past day.
Buy
70
PDEX alert for Jan 7
Pro-Dex [PDEX] is down 10.89% over the past day.
Buy
52
ALCO alert for Jan 7
Alico [ALCO] is down 3.89% over the past day.
